These ASX 200 shares could rise 25% to 60%

Brokers are tipping these shares to deliver outsized returns for investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are hunting for big returns for your investment portfolio, then look no further than the ASX 200 shares in this article.

That's because analysts are tipping them to rise by 25%+ over the next 12 months. Here's what you need to know about them:

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.

Image source: Getty Images

Flight Centre Travel Group Ltd (ASX: FLT)

The team at Macquarie thinks that this travel agent giant is a cheap ASX 200 share to buy right now.

While it wasn't blown away with its full year results in FY 2025, it believes its valuation is attractive and expects improvements in macro conditions to drive strong performances from its key segments. It said:

Outperform. While profit disappointed, both segments delivered solid TTV growth which should accelerate if macro conditions are more supportive. Valuation is attractive, and we see material upside to the current share price over a 12m view.

Macquarie has an outperform rating and $16.55 price target on Flight Centre's shares. Based on its current share price of $13.03, this implies potential upside of 27% for investors over the next 12 months.

In addition, it is forecasting a fully franked dividend yield of 3% in FY 2026, which boosts the total potential return to 30%.

Telix Pharmaceuticals Ltd (ASX: TLX)

Analysts at Bell Potter think that big returns could be coming for patient investors with this beaten down radiopharmaceuticals company's shares.

Although it concedes that this year has been tough for approvals (most recently the denial of Zircaix by the US FDA), it remains very positive on its longer term outlook and appears to see the recent share price weakness as a buying opportunity. It said:

The previous forecast included modest revenues from Zircaix in FY26 ($31m) which is now stripped out and EBITDA is reduced by $13m. The company does not plan to curtail any R&D spend at this point as it remains well capitalised and we expect will continue to generate cash from operations. This is the second CRL for TLX this calendar year. The delay to revenues and knock on effect to the cost of capital (risk) and valuation are material, accordingly our TP is reduced.

Bell Potter has put a buy rating and $23.00 price target on the ASX 200 share. Based on its current share price of $14.60, this suggests that upside of almost 60% is possible for investors between now and this time next year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Flight Centre Travel Group and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A couple sitting in their living room and checking their finances.
Broker Notes

Buy, hold, sell: CSL, Magellan, and Woodside shares

Do analysts think these blue-chips are in the buy zone? Let's find out.

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Broker Notes

Up 32% this week, are Guzman Y Gomez shares a good buy today?

A leading analyst delivers his outlook for Guzman Y Gomez shares.

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.
Broker Notes

Buy, hold, or sell? Bubs, Soul Patts, and Endeavour shares

Experts have reviewed their ratings on these ASX shares.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares tipped to grow 100% or more in the next 12 months

These stocks across three sectors could be deeply undervalued, analysts say.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

3 reasons to buy Capstone Copper shares today

A leading analyst expects more outperformance from Capstone Copper’s surging shares. But why?

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Broker Notes

What is this broker's view on Magellan Financial Group after yesterday's disappointing results

Where to next for this funds manager?

Read more »

A woman is excited as she reads the latest rumour on her phone.
Broker Notes

This ASX industrials stock could be set to double according to one broker

This ASX small-cap could be one to keep an eye on.

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Broker Notes

What's Bell Potter's updated view on CSL shares?

Will the new tariffs impact CSL according to Bell Potter?

Read more »